Andrographolide nanoparticles in leishmaniasis: characterization and in vitro evaluations

References

• CavalliABolognesiMLNeglected tropical diseases: multi-target- directed ligands in the search for novel lead candidates against Trypanosoma and LeishmaniaJ Med Chem200952237339735919606868
   PubMed Web of Science ®Google Scholar
• ConnellDONeglected diseasesNature20074497159157
   Web of Science ®Google Scholar
• OuelletteMDrummelsmithJPapadopoulouBLeishmaniasis: drugs in the clinic, resistance and new developmentsDrug Resist Updat2004745257266
   Web of Science ®Google Scholar
• CroftSLCoombsGHLeishmaniasis – current chemotherapy and recent advances in the search for novel drugsTrends Parasitol2003191150250814580961
   PubMed Web of Science ®Google Scholar
• SeifertKCroftSLIn vitro and in vivo interactions between miltefosine and other antileishmanial drugsAntimicrob Agents Chemother2006501737916377670
   PubMed Web of Science ®Google Scholar
• SinhaJMukhopadhyaySDasNBasuMKTargeting of liposomal andrographolide to L. donovani-infected macrophages in vivoDrug Deliv20007420921311195427
   PubMed Web of Science ®Google Scholar
• ZhaoDLiaoKMaXYanXStudy of the supramolecular inclusion of β-cyclodextrin with andrographolideJ Incl Phenom Macrocycl Chem20024334259264
   Web of Science ®Google Scholar
• ZhuSPKangBADistribution and excretion of [35S] NaHSO3 – andrographolide by autoradiographyActa Pharmacologica Sinica1981242662696462028
   PubMedGoogle Scholar
• BalaIBhardwajVHariharanSKharadeSVRoyNRavi KumarMNSustained release nanoparticulate formulation containing antioxidantellagic acid as potential prophylaxis system for oral administrationJ Drug Target2006141273416603449
   PubMed Web of Science ®Google Scholar
• SarmentoBRibeiroAJVeigaFFerreiraDCNeufeldRJInsulin- loaded nanoparticles are prepared by alginate ionotropic pregelation followed by chitosan polyelectrolyte complexationJ Nanosci Nanotechnol2007781917455473
   PubMed Web of Science ®Google Scholar
• ChakrabortyPDasPKRole of mannose/N-acetylglucosamine receptors in blood clearance and cellular attachment of Leishmania donovaniMol Biochem Parasitol198828155623374526
   PubMed Web of Science ®Google Scholar
• GhoshAKBhattacharyaFKGhoshDKLeishmania donovani: amastigote inhibition and mode of action of berberineExp Parasitol19856034044134076392
   PubMed Web of Science ®Google Scholar
• DebrabantAJoshiMBPimentaPFDwyerDGeneration of Leishmania donovani axenic amastigotes: their growth and biological characteristicsInt J Parasitol200434220521715037106
   PubMed Web of Science ®Google Scholar
• SeneroDLemesraJLAxenically cultured amastigote forms as an in-vitro model for investigation of antileishmanial agentsAntimicrob Agents Chemother19974159729769145854
   PubMed Web of Science ®Google Scholar
• CallahanHKelleyCPeretraTGrogleMMicrotubule inhibitors: structure-activity analysis suggest rational models to identify potentially active compoundsAntimicrob Agents Chemother19964049479528849257
   PubMed Web of Science ®Google Scholar
• ChangKHuman cutaneous leishmaniasis in a mouse macrophage line: propagation and isolation of intracellular parasitesScience19802094462124012447403880
   PubMed Web of Science ®Google Scholar
• FreitasMNMarchettiJMNimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseasesInt J Pharm20052951220121115847986
   PubMed Web of Science ®Google Scholar
• BudhianASiegelSJWineyKIHaloperidol-loaded PLGA nanoparticles: Systemic study of particle size and drug contentInt J Pharm2007336236737517207944
   PubMed Web of Science ®Google Scholar
• BellamyLJThe Infrared Spectra of Complex Molecules2nd edPt 1New YorkChapman and Hall19803056
   Google Scholar
• MukherjeeBSantraKPatttanaikGGhoshSPreparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymersInt J Nanomed200834487496
   PubMed Web of Science ®Google Scholar
• KorsemeyerRWGurnyRDoelkerEMBuriPPeppasNAMechanism of solute release from porous hydrophilic polymersInt J Pharm19831512535
   Web of Science ®Google Scholar
• GrattardNPerninMMartyBRoudautGChampionDMesteMLStudy of release kinetics of small and high molecular weight substances dispersed into spray-dried ethylcellulose microspheresJ Control Rel2002843125135
   PubMed Web of Science ®Google Scholar
• Ponte-SucreAPhysiological consequences of drug resistance in Leishmania and their relevance for chemotherapyKinetoplastid Biol Dis20032111012769824
   PubMedGoogle Scholar
• LalaSPramanikSMukhopadhaySBandhopadhyaySBasuMKHarmine: evaluation of its antileishmanial properties in various vesicular delivery systemsJ Drug Target200412316517515203896
   PubMed Web of Science ®Google Scholar
• CruzLJLuque-OrtegaJRRivasLAlbericioFKahalalideFAn antitumor depsipeptide in clinical trials, and its analogues as effective antileishmanial agentsMol Pharm20096381382419317431
   PubMed Web of Science ®Google Scholar
• HabtemariamSIn vitro antileishmanial effects of antibacterial diterpenes from two Ethiopian Premna species: P. schimperi and P. oligotrichaBMC Pharmacol2003361612513698
   PubMedGoogle Scholar
• MishraSKSangwanNSSangwanRSAndrographis paniculata (Kalmegh): A ReviewPharmacognosy Reviews200712283298
   Google Scholar
• CavaMPChanWRHaynesLJJohnsonLFWeinsteinBThe structure of andrographolideTetrahedron1962184397403
   Web of Science ®Google Scholar
• LalaSNandyAKMahatoSBBasuMKDelivery in vivo of 14- deoxy-11-oxoandrographolide, an antileishmanial agent, by different drug carriersIndian J Biochem Biophys20032169174
   Google Scholar
• WinKYFengSSEffects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugsBiomaterials200526152713272215585275
   PubMed Web of Science ®Google Scholar
• VasirJKReddyMKLabhasetwarVDNanosystems in drug targeting: Opportunities and ChallengesCurr Nanosci2005114764
   Web of Science ®Google Scholar
• MundargiRCBabuVRRangaswamyVPatelPAminabhaviTMNano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivativesJ Control Release2008125319320918083265
   PubMed Web of Science ®Google Scholar